Menu Search
Equities

Dr. Lal PathLabs Ltd

LALPATHLAB:NSI

Dr. Lal PathLabs Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)2,960.45
  • Today's Change2.15 / 0.07%
  • Shares traded9.23k
  • 1 Year change+12.87%
  • Beta0.7474
Data delayed at least 15 minutes, as of Nov 14 2024 03:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Dr. Lal PathLabs Ltd grew revenues 10.40% from 20.17bn to 22.27bn while net income improved 49.78% from 2.39bn to 3.58bn.
Gross margin80.28%
Net profit margin17.33%
Operating margin21.95%
Return on assets16.13%
Return on equity21.27%
Return on investment20.12%
More ▼

Cash flow in INRView more

In 2024, Dr. Lal PathLabs Ltd increased its cash reserves by 36.86%, or 972.02m. The company earned 5.35bn from its operations for a Cash Flow Margin of 24.04%. In addition the company used 242.69m on investing activities and also paid 4.14bn in financing cash flows.
Cash flow per share65.91
Price/Cash flow per share45.96
Book value per share240.30
Tangible book value per share140.97
More ▼

Balance sheet in INRView more

Dr. Lal PathLabs Ltd has a Debt to Total Capital ratio of 8.89%, a lower figure than the previous year's 9.33%.
Current ratio2.87
Quick ratio2.77
Total debt/total equity0.0992
Total debt/total capital0.0889
More ▼

Growth rates in INR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 100.00% and 49.56%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.74%
Div growth rate (5 year)31.95%
Payout ratio (TTM)24.89%
EPS growth(5 years)12.22
EPS (TTM) vs
TTM 1 year ago		33.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.